Liver steatosis is the most widespread chronic liver condition. Its global incidence is rising
swiftly and is currently estimated to be 24%. Liver steatosis is strongly related with numerous …

The gut–liver axis represents complex pathways of communication between the gut, the gut
microbiota, and the liver that influence hepatic and systemic health. Hepatic steatosis …

Chronic liver disease encompasses diseases that have various causes, such as alcoholic
liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD). Gut microbiota …

Simple Summary Dysfunctional gut microbiota leads to the activation of multiple pathways in
the gut and in the liver that sustain hepatic inflammation and are involved in the …

Numerous studies show a modification of the gut microbiota in patients with obesity or
diabetes. Animal studies have also shown a causal role of gut microbiota in liver metabolic …

Nonalcoholic fatty liver disease (NAFLD) is the accumulation of fat in the liver in the absence
of secondary causes. NAFLD is a multifactorial disease that results from the interaction of …

Metabolic-associated fatty liver disease (MAFLD) is one of the most common chronic liver
diseases worldwide. In recent years, the occurrence rate of MAFLD has been on the rise …

Fatty liver disease (FLD) is one of the largest burdens to human health worldwide and is
associated with gut microbiome and metabolite stability. Engineered liver tissues have …

Non-alcoholic fatty liver disease (NAFLD) is one of the most common metabolic diseases
currently in the context of obesity worldwide, which contains a spectrum of chronic liver …

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a prevalent and challenging
disease associated with a significant health and economic burden. MAFLD has been …